Regulation of the mitochondrial calcium uniporter

线粒体钙单向转运蛋白的调节

基本信息

  • 批准号:
    10539759
  • 负责人:
  • 金额:
    $ 56.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-20 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Calcium influx into the mitochondria can potently stimulate ATP synthesis, but excessive levels cause mitochondrial failure and cell death. Such calcium overload is a prominent pathological pathway in disease in multiple organ systems. In the heart, this phenomenon is noted during heart attacks, when prolonged ischemia causes calcium to accumulate in the cytoplasm and subsequently overload mitochondria. In heart failure, mitochondrial are also more susceptible to calcium overload. Calcium enters the mitochondria through a multi-subunit calcium-activated channel known as the mitochondrial calcium uniporter. In animal models, genetic inhibition of the uniporter has appeared protective in acute disease. In chronic diseases, though inhibition of calcium overload is protective, there may also be basal requirements for milder mitochondrial calcium uptake. Currently, however, there are no specific therapies to prevent calcium overload or its downstream affects. Pharmacological modulation of the uniporter in vivo is limited by agents that are poorly selective, cell impermeable, or produce off-target effects. A critical gap in the ability to better modulate the uniporter is our limited understanding of how the pore-forming subunit, MCU, is regulated. Recent elegant structural studies have revealed the architecture of the uniporter complex, and mechanisms for calcium selectivity and gating, setting the stage for structure-function investigations of further channel regulation. In this proposal, the principal investigators apply their complementary skills in structural biology and mitochondrial functional assays to define pharmacological and protein-based mechanisms for such channel regulation. First, using a combination of computational, electrophysiological, and structural approaches, we will investigate uniporter inhibitors that are cell-permeable and specific, and useful for either acute or chronic injury. Second, using new molecular tools, mutagenesis, and structural biology, we will identify how the uniporter subunit MCUB leads to inhibition of calcium uptake through the uniporter. Taken together, our studies will reveal novel forms of uniporter regulation that may be developed into therapies for cardiovascular and other disorders.
项目摘要 钙流入线粒体可以有效地刺激ATP的合成,但过量的水平会导致 线粒体衰竭和细胞死亡。这种钙超载是一个突出的病理途径,在疾病 在多器官系统中。在心脏中,这种现象在心脏病发作期间被注意到, 局部缺血导致钙在细胞质中积累,随后使线粒体过载。心脏 失败,线粒体也更容易受到钙超载。钙进入线粒体 通过称为线粒体钙单向转运体的多亚基钙激活通道。在动物 模型中,单向转运蛋白的遗传抑制在急性疾病中表现出保护作用。在慢性病中, 虽然抑制钙超载是保护性的,但也可能存在轻度钙超载的基础要求。 线粒体钙摄入。然而,目前还没有具体的治疗方法来预防钙 超负荷或其下游影响。体内单向转运体的药理学调节受试剂限制 其选择性差、细胞不可渗透或产生脱靶效应。一个关键的差距, 调节单向转运蛋白是我们对孔形成亚基MCU如何调节的有限理解。 最近的结构研究揭示了单向转运蛋白复合体的结构和机制 对于钙选择性和门控,为进一步的通道结构-功能研究奠定了基础。 调控在这个建议中,主要研究者运用他们在结构生物学方面的互补技能 和线粒体功能测定来确定这种作用的药理学和基于蛋白质的机制。 渠道监管首先,使用计算、电生理和结构的组合, 方法,我们将研究单向转运蛋白抑制剂,是细胞渗透性和特异性,并用于 急性或慢性损伤。第二,利用新的分子工具,诱变和结构生物学,我们将 确定单向转运蛋白亚基MCUB如何通过单向转运蛋白抑制钙摄取。采取 总之,我们的研究将揭示单向转运蛋白调节的新形式,这些形式可能被开发成治疗 心血管和其他疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dipayan Chaudhuri其他文献

Dipayan Chaudhuri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dipayan Chaudhuri', 18)}}的其他基金

Regulation of the mitochondrial calcium uniporter
线粒体钙单向转运蛋白的调节
  • 批准号:
    10668475
  • 财政年份:
    2022
  • 资助金额:
    $ 56.41万
  • 项目类别:
Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies
线粒体钙摄取增强对线粒体心肌病的代谢影响和机制
  • 批准号:
    9913592
  • 财政年份:
    2018
  • 资助金额:
    $ 56.41万
  • 项目类别:
Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies
线粒体钙摄取增强对线粒体心肌病的代谢影响和机制
  • 批准号:
    10391325
  • 财政年份:
    2018
  • 资助金额:
    $ 56.41万
  • 项目类别:
Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies
线粒体钙摄取增强对线粒体心肌病的代谢影响和机制
  • 批准号:
    10753651
  • 财政年份:
    2018
  • 资助金额:
    $ 56.41万
  • 项目类别:
Structural basis for mitochondrial calcium uniporter function
线粒体钙单向转运蛋白功能的结构基础
  • 批准号:
    9208793
  • 财政年份:
    2014
  • 资助金额:
    $ 56.41万
  • 项目类别:
Structural basis for mitochondrial calcium uniporter function
线粒体钙单向转运蛋白功能的结构基础
  • 批准号:
    8959727
  • 财政年份:
    2014
  • 资助金额:
    $ 56.41万
  • 项目类别:
Structural basis for mitochondrial calcium uniporter function
线粒体钙单向转运蛋白功能的结构基础
  • 批准号:
    9203682
  • 财政年份:
    2014
  • 资助金额:
    $ 56.41万
  • 项目类别:
Structural basis for mitochondrial calcium uniporter function
线粒体钙单向转运蛋白功能的结构基础
  • 批准号:
    8897438
  • 财政年份:
    2014
  • 资助金额:
    $ 56.41万
  • 项目类别:
Identification of a Stretch-Activated Channel with a Role in Cardiac Development
鉴定在心脏发育中起作用的牵拉激活通道
  • 批准号:
    8423352
  • 财政年份:
    2011
  • 资助金额:
    $ 56.41万
  • 项目类别:
Identification of a Stretch-Activated Channel with a Role in Cardiac Development
鉴定在心脏发育中起作用的牵拉激活通道
  • 批准号:
    8059366
  • 财政年份:
    2011
  • 资助金额:
    $ 56.41万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 56.41万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了